# Wound Healing Physiology and Factors Affecting Repair


## Key Takeaways

- Wound healing progresses through overlapping inflammatory, proliferative, and remodeling phases, each regulated by cellular interactions, growth factors, and extracellular matrix components; disruption at any stage, such as by infection or ischemia, prolongs healing and increases complication risk.
- The inflammatory phase (Days 0-5) involves hemostasis, neutrophil recruitment for debridement, and macrophage activation for cytokine and growth factor release, with persistent inflammation indicated by chronic exudate and non-viable tissue.
- The proliferative phase (Days 3-14) is characterized by fibroblast-driven collagen synthesis, angiogenesis forming granulation tissue, and epithelialization from wound margins; healthy granulation tissue is bright red and moist, while pale or friable tissue suggests poor perfusion or infection.
- The remodeling phase (Day 7-months) involves collagen reorganization and tensile strength gain, with type III collagen replaced by type I, achieving 70-80% of original skin strength; excessive inflammation can lead to hypertrophic scarring.
- Local factors impairing healing include infection (bacterial burden >10^5 organisms/gram), ischemia, foreign material, motion, and desiccation, while systemic factors encompass advanced age, diabetes mellitus, malnutrition, hypercortisolemia, and uremia.
- Species differences are clinically relevant: cats exhibit slower granulation tissue formation and greater reliance on wound contraction compared to dogs, necessitating adjusted timelines for surgical planning and closure.

---

This article reviews the biological phases of cutaneous wound repair in dogs and cats and the systemic and local factors that modulate healing outcomes. It is written for practicing veterinarians who manage acute and chronic wounds and need a physiologically grounded framework for treatment decisions, prognostic counseling, and complication recognition. The content integrates comparative physiology, clinical pathology, and practical monitoring parameters, with attention to species differences between dogs and cats where they are clinically relevant.

Wound healing proceeds through overlapping phases of inflammation, proliferation, and remodeling, each governed by coordinated interactions among inflammatory cells, growth factors, extracellular matrix components, and resident tissue cells [Open pilonidal excision as a translational human model for wound healing and skin regeneration research](https://pubmed.ncbi.nlm.nih.gov/42072292/). Disruption at any stage, whether from infection, ischemia, metabolic disease, or nutritional deficiency, prolongs healing and increases the risk of complications. A working knowledge of these mechanisms allows the clinician to identify why a wound is failing to progress and to select interventions that target the specific deficit.

## At a Glance

| Parameter | Clinical Relevance |
|---|---|
| Inflammatory phase duration | Days 0 to 5 post-injury, prolonged inflammation predicts delayed healing |
| Proliferative phase | Days 3 to 14, granulation tissue formation and epithelialization |
| Remodeling phase | Day 7 to months, collagen reorganization and tensile strength gain |
| Nitric oxide | Regulates inflammatory and proliferative cellular activity, deficiency impairs repair |
| Cat vs dog healing | Cats show slower granulation tissue formation and greater reliance on contraction |
| Local factors | Infection, ischemia, foreign material, motion, desiccation |
| Systemic factors | Age, diabetes, malnutrition, hypercortisolemia, uremia |
| Wound assessment | Serial measurement of area, exudate, granulation quality, and epithelial margin |

## The Phases of Cutaneous Repair

### Inflammatory Phase

Tissue injury disrupts vasculature and triggers immediate hemostasis through platelet aggregation and fibrin clot formation. Platelets release growth factors and chemokines that recruit neutrophils within hours. Neutrophils clear contaminating bacteria and debris through phagocytosis and degranulation. By day 2 to 3, circulating monocytes enter the wound and differentiate into macrophages, which become the dominant regulatory cells of the repair process. Macrophages phagocytose apoptotic neutrophils, release cytokines that drive fibroblast recruitment, and secrete growth factors that stimulate angiogenesis.

The inflammatory phase is tightly regulated. Pro-inflammatory cytokines initiate the response, while anti-inflammatory mediators limit its duration and prevent excessive tissue damage. Persistent inflammation, as occurs with infection or retained foreign material, shifts the wound into a chronic state. The clinical hallmark is a wound that fails to progress past the inflammatory stage, with persistent exudate, erythema, and non-viable tissue at the wound bed.

### Proliferative Phase

As inflammation subsides, the proliferative phase begins. Fibroblasts migrate into the wound, proliferate, and synthesize collagen and proteoglycans. New capillaries sprout from adjacent vessels in response to hypoxia and angiogenic growth factors, forming granulation tissue. This tissue provides a vascularized bed over which epithelial cells migrate from the wound margins. Epithelialization proceeds from the edges and from residual hair follicles and glandular structures in partial-thickness wounds.

Granulation tissue quality is a useful clinical indicator of healing progress. Healthy granulation tissue is bright red, moist, and uniform in texture. Pale, friable, or hyperplastic granulation tissue suggests poor perfusion, infection, or excessive motion. In cats, granulation tissue formation is slower and often less robust than in dogs, and epithelialization tends to be more dependent on wound contraction.

### Remodeling Phase

The remodeling phase begins approximately one week after injury and continues for months. Collagen is continuously degraded and resynthesized, with type III collagen gradually replaced by type I collagen. Fibers align along lines of tensile stress, and wound strength increases progressively. A healed wound typically achieves only 70 to 80 percent of the tensile strength of intact skin, and this maximum is reached months after closure.

Remodeling is influenced by mechanical load, species, and the presence of ongoing inflammation. Excessive or prolonged inflammation during this phase leads to hypertrophic scar formation or, in some cases, chronic non-healing wounds. The comparative biology of repair is instructive: some vertebrates regenerate dermis after injury, while mammals typically replace it with scar tissue, a difference that reflects the intercellular control systems governing the healing response [Advances in wound healing physiology: the comparative perspective](https://pubmed.ncbi.nlm.nih.gov/34645022/).

## Growth Factors and Signaling Mediators

Growth factors are polypeptide signaling molecules that coordinate cellular proliferation, migration, and differentiation throughout healing. Key families include platelet-derived growth factor, transforming growth factor beta, fibroblast growth factor, epidermal growth factor, and vascular endothelial growth factor. These factors act in sequence, with overlapping temporal expression patterns that shift the wound from inflammation to proliferation to remodeling.

Nitric oxide has emerged as a critical regulatory molecule in wound repair. It exerts control over cellular activities in both the inflammatory and proliferative phases, influencing vasodilation, angiogenesis, and immune cell function [Role of nitric oxide in wound healing](https://pubmed.ncbi.nlm.nih.gov/12363282/). Nitric oxide is synthesized from L-arginine by nitric oxide synthase enzymes, and its production is increased in healing wounds. Impaired nitric oxide synthesis, as occurs with advanced age, malnutrition, or ischemia, is associated with delayed healing. This has therapeutic implications, since strategies that support nitric oxide availability may improve outcomes in compromised wounds.

## Species Differences in Healing

Dogs and cats differ in clinically meaningful ways. Dogs typically produce robust granulation tissue within 3 to 5 days and heal open wounds efficiently by a combination of contraction and epithelialization. Cats produce granulation tissue more slowly, often requiring 5 to 7 days or longer, and their wounds are more prone to dehiscence and delayed closure. Feline skin is thinner and more fragile, and cats appear to have a less vigorous inflammatory response, which may contribute to slower debridement of devitalized tissue.

These differences affect surgical planning. A wound that would be closed secondarily in a dog after 4 days of granulation may require a longer delay in a cat. Similarly, the decision to use skin grafts or flaps must account for the reduced vascularity and slower integration of grafted tissue in cats. The clinician should communicate realistic timelines to owners and schedule rechecks accordingly.

## Factors That Impair Healing

### Local Factors

Infection is the most common local cause of delayed healing. Bacterial burden above a critical threshold prolongs inflammation, consumes oxygen and nutrients, and produces proteases that degrade the extracellular matrix. Wounds with greater than 10^5 organizms per gram of tissue are generally considered infected, though this threshold varies with bacterial species and host immune status.

Ischemia from vascular compromise, excessive tension, or tight bandaging impairs all phases of healing. Hypoxia limits collagen synthesis and angiogenesis and reduces the oxidative burst of neutrophils. Foreign material, including suture, dirt, and necrotic tissue, perpetuates inflammation and provides a nidus for infection. Motion at the wound site disrupts newly formed capillaries and collagen fibrils, delaying granulation and epithelialization. Desiccation of the wound surface kills exposed cells and slows epithelial migration.

### Systemic Factors

Advanced age is associated with diminished immune function and a less efficient healing response [Role of nitric oxide in wound healing](https://pubmed.ncbi.nlm.nih.gov/12363282/). Older animals show delayed inflammation, reduced angiogenesis, and slower collagen deposition. Diabetes mellitus impairs healing through multiple mechanisms, including microvascular disease, reduced growth factor expression, and increased susceptibility to infection. Experimental models that combine long-term metabolic stress with aging reproduce the transcriptional signature of impaired healing seen in human diabetic ulcers, underscoring the importance of chronic systemic disease in wound outcomes [An older diabetes-induced mice model for studying skin wound healing](https://pubmed.ncbi.nlm.nih.gov/36800369/).

Malnutrition, particularly protein deficiency, limits the substrate for collagen synthesis and immune function. Hypercortisolemia, whether endogenous or iatrogenic, suppresses inflammation and fibroplasia. Uremia impairs platelet function and fibroblast activity. Hypothyroidism and other endocrine disorders may also contribute to delayed healing, though the evidence base in veterinary patients is limited.

## Clinical Implications

Wound management should be guided by the phase of healing and the factors that are actively impairing progress. Serial assessment of wound area, exudate character, granulation tissue quality, and epithelial margin advancement provides objective data on whether healing is proceeding normally. A wound that fails to show measurable improvement within 5 to 7 days warrants investigation for infection, ischemia, foreign material, or an unrecognized systemic disease.

Therapeutic decisions should target the specific deficit. Infection requires debridement and appropriate antimicrobial therapy. Ischemia requires improved vascular support, reduced tension, or reconstructive surgery. Nutritional support should address protein and micronutrient requirements. In all cases, the clinician should consult current formulary and label references for drug selection and dosing, since recommendations vary by species and jurisdiction.

## Clinical Assessment of the Healing Wound

Serial evaluation is the foundation of wound management. The clinician must distinguish normal progression from stagnation or deterioration. Assessment begins at each bandage change and should follow a consistent sequence: visual inspection, odour detection, palpation of surrounding tissues, measurement of the wound dimensions, and documentation of exudate character and volume.

Visual inspection should note the color and character of the wound bed. Healthy granulation tissue appears red to deep pink, moist, and finely nodular. A pale or boggy bed suggests poor perfusion or excessive edema. A dark red to purple bed with easy hemorrhage indicates bacterial overgrowth or ischemia. Necrotic tissue appears grey, black, or green and must be distinguished from adherent fibrin, which is yellow and fibrinous but potentially removable with lavage.

Odour is a useful but underused parameter. A sweet, musty odour may accompany necrotic tissue. A putrid odour suggests anaerobic infection. The absence of odour does not exclude infection, particularly in early biofilm formation.

Palpation of the wound margin and surrounding skin provides information about perfusion, swelling, and pain. Induration beyond the wound edge suggests cellulitis or deep infection. Crepitus indicates gas-producing organizms. The wound margin should be assessed for epithelial advancement, which appears as a thin, pale rim of new epidermis advancing from the edges. Epithelialisation of 1 to 2 mm per day is expected in healthy wounds healing by second intention, though this rate varies with wound size, location, and patient factors.

Serial wound measurement is essential. Tracing the wound perimeter onto sterile transparent film or using calibrated digital photography allows objective tracking of surface area. Depth should be measured with a sterile probe or ruler at the deepest point. Volume can be estimated by filling the wound with sterile saline in a syringe, though this is impractical for most clinical settings. A consistent measurement technique, performed by the same observer where possible, reduces inter-observer variability.

Documentation should include the date, wound dimensions, percentage of wound bed composed of granulation tissue versus necrotic or fibrinous material, exudate characteriztics, odour, margin appearance, and any complications. Photographs taken at each bandage change provide a longitudinal record that is more reliable than written descriptions alone.

## Monitoring Parameters and Their Interpretation

| Parameter | Normal Finding | Abnormal Finding | Clinical Significance |
|---|---|---|---|
| Wound bed color | Red to deep pink, moist | Pale, boggy, or cyanotic | Poor perfusion, edema, or early ischemia |
| Granulation tissue | Finely nodular, uniform | Hypertrophic, exophytic, or hemorrhagic | Excessive inflammation, infection, or foreign material |
| Exudate volume | Decreasing over time | Increasing or persistent | Infection, biofilm, or inadequate drainage |
| Exudate character | Serous to serosanguinous | Purulent, malodorous, or discoloured | Bacterial or anaerobic infection |
| Wound margin | Flat, advancing epithelium | Raised, rolled, or undermined | Infection, neoplasia, or mechanical irritation |
| Surrounding skin | Normal color and temperature | Erythema, heat, induration | Cellulitis or deep infection |
| Pain on palpation | Decreasing | Increasing or disproportionate | Infection, ischemia, or neuropathic pain |
| Wound dimensions | Steady decrease | Static or increasing | Failure of repair, infection, or ongoing trauma |

A wound that fails to show measurable reduction in surface area over 7 to 14 days warrants reassessment. The clinician should reconsider the adequacy of debridement, the presence of foreign material, the bacterial burden, and the patient's systemic status. Persistent non-healing beyond 3 to 4 weeks in an otherwise healthy patient should prompt biopsy to rule out neoplasia or an underlying immune-mediated process.

## Decision Points in Wound Management

The first decision point is whether to close the wound primarily, to close it in a delayed manner, or to allow healing by second intention. This decision is made at initial presentation and depends on wound age, contamination, tissue viability, and patient stability. Wounds older than 6 to 8 hours, heavily contaminated wounds, and wounds with devitalised tissue are generally managed open with delayed closure once a healthy granulation bed forms. The [American College of Veterinary Surgeons small animal resources](https://www.acvs.org/small-animal/) provide guidance on surgical decision-making and expected outcomes for common wound presentations.

The second decision point is the timing of repeat debridement. Wounds with progressive necrosis or established infection require debridement every 24 to 48 hours until the bed is clean and viable. The decision to stop debridement is based on the appearance of healthy granulation tissue and the absence of necrotic material, not on a fixed timeline.

The third decision point is the transition from open wound management to closure or grafting. This occurs when the wound bed is covered by healthy granulation tissue, bacterial burden is controlled, and the wound margins are not undermined. For wounds healing by second intention, the decision is whether to continue conservative management or to intervene surgically if epithelialisation stalls.

The fourth decision point involves the choice of topical therapy. This is guided by the wound stage. During the inflammatory phase, moisture-retentive dressings and lavage are appropriate. During the proliferative phase, dressings that support granulation tissue formation are selected. During the epithelialisation phase, a moist environment that does not macerate the advancing epithelium is preferred. The [MSD Veterinary Manual professional edition](https://www.msdvetmanual.com/) provides species-specific guidance on wound care products and their indications.

## Modifiable Factors in Wound Repair

Several factors that impair healing can be modified by the clinician. These are presented as a practical checklist.

| Factor | Clinical Intervention | Monitoring |
|---|---|---|
| Bacterial burden | Debridement, lavage, appropriate topical antisepsis, systemic antibiotics when indicated | Wound bed appearance, exudate, odour, culture when non-healing |
| Necrotic tissue | Surgical debridement, enzymatic agents, wet-to-dry dressings | Percentage of viable bed |
| Foreign material | Exploration, imaging when suspected, removal | Wound bed character, persistent drainage |
| Desiccation | Moisture-retentive dressings | Wound bed moisture, eschar formation |
| Edema | Compression bandaging, limb elevation, treatment of underlying cause | Limb circumference, wound bed color |
| Nutritional status | Nutritional assessment, protein and micronutrient supplementation | Body condition, serum albumin, wound healing rate |
| Endocrine disease | Glycaemic control in diabetic patients, management of hyperadrenocorticism | Serial glucose or fructosamine, healing progress |
| Drug effects | Review of glucocorticoid and other immunosuppressive therapy | Healing rate, wound bed appearance |
| Self-trauma | Elizabethan collars, bandage protection, behavioral management | Wound margin integrity, bandage condition |

Nutritional support deserves particular emphasis. Protein deficiency delays all phases of repair. Vitamin C is required for collagen synthesis, and zinc is a cofactor for DNA polymerase and matrix metalloproteinases. In patients with known deficiencies or prolonged healing, targeted supplementation is reasonable, though routine supplementation in well-nourished patients has not been shown to accelerate repair.

## When Healing Fails

Failure of healing follows recognizable patterns. The wound that remains static in size despite appropriate local care most often reflects an uncontrolled bacterial burden or a missed systemic factor. The wound that enlarges despite treatment suggests ongoing trauma, infection, or an inflammatory condition such as pyoderma gangrenosum. The wound that develops exuberant granulation tissue, common in dogs, may respond to topical glucocorticoids once infection is excluded, though this must be balanced against the antiproliferative effects of steroids on epithelialisation.

Cats present a particular challenge. Their healing is slower than that of dogs, and they are prone to excessive fibroplasia and delayed epithelialisation. Feline skin is thinner and more mobile, and wounds often require more conservative debridement to preserve viable tissue. The [MSD Veterinary Manual professional edition](https://www.msdvetmanual.com/) notes species-specific differences in wound repair that influence surgical planning and postoperative care.

Chronic non-healing wounds should be evaluated for biofilm formation. Biofilms are bacterial communities embedded in a polysaccharide matrix that resist both antibiotics and host defenses. They are suspected when a wound fails to respond to apparently appropriate therapy. Management requires mechanical disruption through debridement, the use of agents that penetrate or disrupt the matrix, and frequent dressing changes to prevent reformation.

The role of nitric oxide in wound healing has been investigated as a potential therapeutic target. Nitric oxide exerts regulatory effects on the inflammatory and proliferative phases, and impaired nitric oxide synthesis has been linked to delayed healing in chronic wounds, as described in [a review of nitric oxide in wound healing](https://pubmed.ncbi.nlm.nih.gov/12363282/). Clinical application remains experimental, and no commercial nitric oxide-based therapy is currently standard of care in veterinary practice.

When a wound fails to heal despite optimization of all modifiable factors, biopsy is indicated. Histopathology can identify neoplasia, deep fungal infection, or immune-mediated disease that may not be apparent on gross inspection. Culture of deep tissue, not surface swabs, should be performed when infection is suspected but not confirmed by response to therapy.

## Recognized Complications and Early Detection

Healing failure presents through several recognizable patterns. The most common is delayed progression, where a wound remains in the inflammatory phase beyond the expected interval for its size and location. Serial wound measurement provides the most objective detection method. A wound that fails to reduce in surface area by approximately 10 to 15 percent per week warrants investigation instead of continued expectant management.

Infection remains the most frequently identified complication. Early signs include persistent erythema beyond the wound margin, malodor, increased exudate viscosity, and a change in exudate color from serosanguinous to purulent. Systemic signs such as fever or leukocytosis appear late and should not be awaited. Quantitative bacterial culture, with a threshold of 10^5 colony-forming units per gram of tissue, distinguishes contamination from clinically significant infection. Surface swabs reflect surface flora, not tissue burden, so a biopsy or deep tissue sample is preferred when the distinction matters clinically.

Seroma and hematoma formation present as fluctuant swelling beneath intact skin or at the wound edge. Detection is easiest within the first 48 to 72 hours after closure. Early recognition matters because accumulated fluid separates wound edges, increases tissue tension, and provides a culture medium for bacterial proliferation. Needle aspiration confirms the diagnosis but carries an introduction risk, so strict aseptic technique is mandatory.

Wound dehiscence typically follows one of three mechanisms: suture failure, tissue failure, or infection. Suture failure occurs when knots slip or suture breaks under tension. Tissue failure occurs when the wound margin itself tears, usually because local ischemia, edema, or excessive tension compromised tissue strength. Infection causes dehiscence through collagenolysis and impaired fibroplasia. Detection of partial dehiscence before complete separation requires daily inspection of the wound edge for gaping, discoloration, or serous tracking between sutures.

Fistula formation and sinus tracts indicate deep infection, retained foreign material, or underlying osteomyelitis. Persistent drainage from a small opening after apparent healing should trigger imaging. Contrast fistulography or advanced imaging identifies the tract origin and any associated foreign body.

## Common Errors and Corrective Actions

Less experienced clinicians frequently mistake wound moisture for infection. A healthy granulating wound produces moderate serous exudate, and overzealous drying with frequent topical antiseptics damages granulation tissue. The corrective action is to distinguish exudate character from quantity. Serous fluid with healthy pink granulation beneath does not require antimicrobial therapy.

A second common error involves premature closure of contaminated wounds. Primary closure of a wound with devitalized tissue or established infection predictably fails. The corrective framework requires staged management: initial debridement and open drainage, a period of wound bed preparation, then delayed primary closure or secondary closure once the bed supports healing.

Inadequate debridement ranks among the most consequential errors. Necrotic tissue and foreign material perpetuate inflammation and serve as bacterial substrate. The tendency to preserve marginally viable tissue, particularly in areas of cosmetic concern, prolongs healing and increases infection risk. Serial debridement is often necessary, and the clinician should plan for repeated evaluation instead of expecting a single procedure to suffice.

Bandage-related errors include excessive pressure causing ischemia, insufficient padding over bony prominences, and leaving dressings unchanged too long. A dressing that remains dry on the surface while the wound bed remains moist is the goal. Strike-through of exudate to the outer layer indicates the dressing change interval is too long.

## Limitations of Current Evidence

The wound healing literature relies heavily on rodent models that do not fully replicate human or companion animal physiology. The translational gap is substantial, and findings from experimental models frequently fail to predict clinical outcomes in veterinary patients. Diabetes models, for example, often induce acute metabolic derangement instead of the chronic, age-associated metabolic stress that characterizes clinical disease. Extrapolation from these models to dogs and cats requires caution.

Nitric oxide research illustrates both promise and uncertainty. Nitric oxide exerts regulatory effects on inflammatory and proliferative cellular activities, and gene therapy approaches in animal studies have shown encouraging results. However, commercial growth factor products have not demonstrated consistent efficacy in chronic wounds, and the evidence base for their use in veterinary patients remains thin.

Expert opinion diverges on several practical points. The optimal dressing selection for specific wound stages lacks comparative trial data. The role of negative pressure wound therapy in routine small animal practice continues to evolve. Whether early active mobilization improves or impairs healing in specific anatomic sites remains contested. Comparative studies across vertebrate species suggest that regenerative capacity varies, but the clinical relevance of these differences for dogs and cats is not fully defined.

## Referral and Escalation Criteria

Referral to a surgical specialist is appropriate when wound management exceeds the resources or expertise of the primary practice. Specific indications include wounds involving joints, body cavities, or major neurovascular structures, wounds requiring reconstructive techniques such as flaps or grafts, and wounds that fail to progress despite appropriate standard care for three to four weeks.

Specialist consultation should also be considered for wounds in anatomically complex regions, including the distal limb where tendon and bone exposure complicates management, and the perineal region where fecal contamination is unavoidable. The American College of Veterinary Surgeons maintains resources describing expected outcomes and postoperative management for complex surgical conditions, which can guide the decision to refer.

Laboratory involvement extends beyond routine hematology and biochemistry. Quantitative tissue culture, histopathology of wound margins to exclude neoplasia, and assessment of nutritional status through albumin and prealbumin measurement may all inform management. For wounds that fail to heal despite correction of identified factors, biopsy is mandatory to exclude underlying neoplasia or immune-mediated disease.

Regulatory reporting obligations vary by jurisdiction. Wounds resulting from suspected animal abuse, bite wounds subject to rabies quarantine, and surgical site infections involving implanted devices may carry reporting requirements. The World Organization for Animal Health terrestrial animal health standards address disease surveillance and reporting obligations that may apply to certain wound-associated infections. Practitioners should consult their regional veterinary authority for applicable requirements.

## Troubleshooting Guide

| Observation | Likely Cause | Discriminating Check |
|---|---|---|
| Wound size static for 2 weeks | Infection, malnutrition, or foreign body | Quantitative tissue culture, serum albumin, imaging for radiopaque foreign material |
| Excessive serous drainage | Bandage friction, exposed tendon, or lymphatic disruption | Inspect wound bed after gentle lavage, assess bandage fit |
| Gray or yellow wound bed | Fibrinous debris or biofilm | Debridement followed by reassessment in 48 hours |
| Malodor with dark exudate | Anaerobic infection or necrotic tissue | Aerobic and anaerobic culture from deep tissue |
| Sudden increase in pain | Ischemia, infection, or dressing pressure | Remove dressing and assess perfusion, evaluate analgesic requirements |
| Wound edge erythema spreading | Cellulitis | Compare margin measurement from previous assessment, systemic signs |
| Persistent sinus tract | Foreign body or osteomyelitis | Contrast study or advanced imaging, surgical exploration |

The MSD Veterinary Manual provides species-specific guidance on wound assessment and management that supports clinical decision-making at each of these junctures.

## Frequently Asked Questions

### How should I document wound healing progression in the medical record?

Document each assessment with a consistent format that includes wound dimensions, depth, tissue type in the wound bed, exudate character and volume, peri-wound skin condition, and pain score. Photographs taken at the same distance and angle with a ruler in frame provide objective comparison across visits. Record the phase of healing observed and any deviation from expected progression. Note the date of each dressing change, the products used, and the patient's response to handling. This documentation supports clinical decisions, client communication, and medicolegal defense. The [American Veterinary Medical Association practice resources](https://www.avma.org/resources-tools) offer guidance on medical record standards that apply to wound care documentation.

### What can I do when advanced wound care products are unavailable or unaffordable?

Standard saline, sterile gauze, and a consistent aseptic technique remain the foundation of wound management. Honey-based dressings, hydrogels, and foam dressings can be substituted with wet-to-dry gauze for debridement or moisture-retentive petrolatum gauze for granulating wounds, provided the wound is reassessed daily. Manuka honey, if available, offers antimicrobial and debridement properties at lower cost than some commercial dressings. Avoid using nonsterile household materials. The [MSD Veterinary Manual professional edition](https://www.msdvetmanual.com/) describes basic wound care protocols that rely on widely available supplies. When product selection is constrained, prioritize wound hygiene, infection control, and protection from self-trauma over dressing sophistication.

### Does wound healing physiology differ between cats and dogs in ways that change my management plan?

Cats heal more slowly than dogs and produce less granulation tissue, particularly in full-thickness wounds. Feline skin has a thinner dermis and different collagen architecture, which contributes to delayed contraction and weaker early tensile strength. Cats also mount a less robust inflammatory response, so wounds may appear quiescent before infection is clinically evident. Plan longer intervals before reassessing granulation tissue in cats and consider earlier surgical closure when the wound bed permits. The [American College of Veterinary Surgeons animal health resources](https://www.acvs.org/small-animal/) summarize species-specific surgical considerations that inform these decisions.

### How do I explain delayed healing to a client without undermining their confidence in treatment?

Use concrete language that links the visible wound to the underlying biological process. Explain that healing proceeds through defined phases and that certain conditions, such as diabetes, advanced age, or infection, slow the transition between phases. The [role of nitric oxide in wound healing](https://pubmed.ncbi.nlm.nih.gov/12363282/) illustrates how comorbid disease compromises immune function and delays repair. Show the client serial photographs to demonstrate progress that may not be obvious day to day. Frame delays as expected complications of the patient's condition instead of treatment failure. Provide a written plan with specific recheck dates and clear criteria for contacting the clinic between visits.

### When should I escalate a nonhealing wound to a specialist or referral center?

Escalate when a wound shows no measurable improvement in size, depth, or tissue quality after 14 days of appropriate local and systemic therapy, or when the wound deteriorates despite treatment. Refer early if the wound involves bone, joint, tendon, or major neurovascular structures, or if the patient has uncontrolled endocrine disease that complicates repair. Wounds that fail to respond to debridement and antimicrobial therapy may harbor biofilm, foreign material, or neoplasia. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) address welfare considerations that apply when a wound causes persistent pain or limits function. Contact the referral service before the wound becomes nonviable, as earlier intervention improves surgical options.

### How does patient age affect wound healing, and should I adjust my monitoring schedule?

Aged animals show delayed inflammation, reduced fibroblast proliferation, and slower collagen deposition compared with young adults. The [older diabetes-induced mice model for studying skin wound healing](https://pubmed.ncbi.nlm.nih.gov/36800369/) demonstrates that age-related metabolic stress produces a transcriptional signature in skin that overlaps with impaired healing states. In geriatric patients, extend the interval between dressing changes only if the wound is stable, and schedule more frequent rechecks during the inflammatory phase. Account for concurrent disease, polypharmacy, and nutritional status when predicting healing time. Do not assume a wound is healing normally simply because the patient is calm and eating.

## Related Clinical & Scientific Guides

* [Perioperative Antibiotic Prophylaxis: Timing and Selection](/knowledge/veterinary-medicine/veterinary-surgery/perioperative-antibiotic-prophylaxis-timing-selection)
* [Surgical Approaches to the Femur and Stifle](/knowledge/veterinary-medicine/veterinary-surgery/surgical-approaches-femur-stifle)
* [Fracture Healing Assessment: Radiographic and Clinical Evaluation](/knowledge/veterinary-medicine/veterinary-surgery/fracture-healing-assessment-radiographic-clinical)


## References and Further Reading

- [Open Pilonidal Excision as a Translational Human Model for Wound Healing and Skin Regeneration Research.](https://pubmed.ncbi.nlm.nih.gov/42072292/). 2026.
- [Role of nitric oxide in wound healing.](https://pubmed.ncbi.nlm.nih.gov/12363282/). 2002.
- [Advances in wound healing physiology: the comparative perspective.](https://pubmed.ncbi.nlm.nih.gov/34645022/). 1997.
- [An older diabetes-induced mice model for studying skin wound healing.](https://pubmed.ncbi.nlm.nih.gov/36800369/). 2023.
- [American College of Veterinary Surgeons Animal Health Resources](https://www.acvs.org/small-animal/). American College of Veterinary Surgeons.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
- [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association.
- [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). WOAH.

## Related Articles

- [Wound Debridement and Lavage Techniques](/knowledge/veterinary-medicine/veterinary-surgery/wound-debridement-lavage-techniques)
- [Fracture Healing Assessment: Radiographic and Clinical Evaluation](/knowledge/veterinary-medicine/veterinary-surgery/fracture-healing-assessment-radiographic-clinical)
- [Postoperative Wound Management: Monitoring and Complications](/knowledge/veterinary-medicine/veterinary-surgery/postoperative-wound-management-monitoring-complications)
- [Suture Removal Timing and Wound Closure Aftercare](/knowledge/veterinary-medicine/veterinary-surgery/suture-removal-timing-wound-closure-aftercare)
- [Wound Classification and Initial Management in Veterinary Patients](/knowledge/veterinary-medicine/veterinary-surgery/wound-classification-initial-management-veterinary)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.